Angiotensin Converting Enzyme Kit (Kinetic Method with FAPGG)

Primary DI

06936595751864

Basic UDI-DI Code

B-06936595751864

Reference

Angiotensin Converting Enzyme Kit (Kinetic Method with FAPGG)

Device Types

None provided

Regulation

Eu Ivdd

Classification

Eu Ivd General

Status

On The Market

Manufacturer

MedicalSystem Biotechnology Co., Ltd.

For the quantitative in vitro determination of Angiotensin Converting Enzyme (ACE) in serum or plasma. Elevated levels of angiotensin converting enzyme (ACE) occur in patients with active sarcoidosis, with tubercolosis, Gaucher’s disease and in many other pathological conditions in lung and liver diseases. ACE is expressed by pulmonary endothelium. It was discovered that ACE increases during acute lung injury. ACE is considered as a reliable indicator for evaluating the severity of lung injury.

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).